真性红细胞增多症-话题@MedSci

#真性红细胞增多症#

7篇内容 | 1057人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2169751, encodeId=395e2169e5179, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a> <a href='/topic/show?id=74a11029119e' target=_blank style='color:#2F92EE;'>#鲁索替尼#</a>, objectTitle=Eur J Haematol：鲁索替尼治疗对羟基脲耐药和/或不耐药的真性红细胞增多症：欧洲观察性研究, objectType=article, longId=801677, objectId=7e8a8016e7e5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668022044810_4754896.jpeg, objectUrl=/article/show_article.do?id=7e8a8016e7e5, replyNumber=0, likeNumber=36, createdTime=2023-11-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7e8a8016e7e5, moduleTitle=Eur J Haematol：鲁索替尼治疗对羟基脲耐药和/或不耐药的真性红细胞增多症：欧洲观察性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e8a8016e7e5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2144444, encodeId=63c82144444c3, content=<a href='/topic/show?id=f1f51562168' target=_blank style='color:#2F92EE;'>#Ropeginterferon#</a> 与标准疗法治疗低危<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>患者的比较, objectTitle=NEJM Evid：Ropeginterferon 与标准疗法治疗低危真性红细胞增多症患者的比较（Low-PV试验）, objectType=article, longId=778364, objectId=4f28e78364fa, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230623/1687551451909_4754896.jpg, objectUrl=/article/show_article.do?id=4f28e78364fa, replyNumber=0, likeNumber=50, createdTime=2023-06-24, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4f28e78364fa, moduleTitle=NEJM Evid：Ropeginterferon 与标准疗法治疗低危真性红细胞增多症患者的比较（Low-PV试验）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f28e78364fa)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=2106355, encodeId=40d42106355bb, content=伴有<a href='/topic/show?id=9c143e122ef' target=_blank style='color:#2F92EE;'>#原发性血小板增多症#</a>和<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>的<a href='/topic/show?id=da48522840a' target=_blank style='color:#2F92EE;'>#急性心肌梗死#</a>患者住院预后, objectTitle=JAHA：伴有原发性血小板增多症和真性红细胞增多症的急性心肌梗死患者住院预后, objectType=article, longId=751973, objectId=a791e51973f0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221215/1671072228118_1739456.jpg, objectUrl=/article/show_article.do?id=a791e51973f0, replyNumber=0, likeNumber=75, createdTime=2022-12-16, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a791e51973f0, moduleTitle=JAHA：伴有原发性血小板增多症和真性红细胞增多症的急性心肌梗死患者住院预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a791e51973f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220405, encodeId=75b11220405ea, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, objectTitle=2018 奥地利建议：真性红细胞增多症的管理, objectType=guider, longId=8830, objectId=770ca1c00161914d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=770ca1c00161914d, replyNumber=0, likeNumber=53, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=770ca1c00161914d, moduleTitle=2018 奥地利建议：真性红细胞增多症的管理, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=770ca1c00161914d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220404, encodeId=9038122040484, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, objectTitle=2018 SIE共识建议：放血疗法治疗真性红细胞增多症, objectType=guider, longId=8749, objectId=93e431c00161106d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=93e431c00161106d, replyNumber=0, likeNumber=0, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93e431c00161106d, moduleTitle=2018 SIE共识建议：放血疗法治疗真性红细胞增多症, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=93e431c00161106d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220403, encodeId=a2b71220403ce, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, objectTitle=真性红细胞增多症诊断与治疗中国专家共识（2016年版）, objectType=guider, longId=4423, objectId=110171c0011e8aa7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=110171c0011e8aa7, replyNumber=0, likeNumber=57, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=110171c0011e8aa7, moduleTitle=真性红细胞增多症诊断与治疗中国专家共识（2016年版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=110171c0011e8aa7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220402, encodeId=d6b41220402ab, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, objectTitle=2018 BSH指南：真性红细胞增多症的诊断和管理, objectType=guider, longId=9344, objectId=2a6f71c0016e0551, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=2a6f71c0016e0551, replyNumber=0, likeNumber=60, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a6f71c0016e0551, moduleTitle=2018 BSH指南：真性红细胞增多症的诊断和管理, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=2a6f71c0016e0551)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220401, encodeId=e3f41220401fc, content=<a href='/topic/show?id=8012e2649f1' target=_blank style='color:#2F92EE;'>#真性红细胞增多症#</a>, objectTitle=2021 ELN建议：合理应用细胞减少药物治疗真性红细胞增多症, objectType=guider, longId=16670, objectId=4073d1c002a031bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=4073d1c002a031bc, replyNumber=0, likeNumber=79, createdTime=2022-05-17, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4073d1c002a031bc, moduleTitle=2021 ELN建议：合理应用细胞减少药物治疗真性红细胞增多症, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=4073d1c002a031bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

真性红细胞增多症

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#真性红细胞增多症# #鲁索替尼#

Eur J Haematol：鲁索替尼治疗对羟基脲耐药和/或不耐药的真性红细胞增多症：欧洲观察性研究

2023-11-20发表于上海

(审核中...)

前往app查看评论内容

#Ropeginterferon# 与标准疗法治疗低危#真性红细胞增多症#患者的比较

NEJM Evid：Ropeginterferon 与标准疗法治疗低危真性红细胞增多症患者的比较（Low-PV试验）

2023-06-24发表于上海

循证小兵 (审核中...)

前往app查看评论内容

伴有#原发性血小板增多症#和#真性红细胞增多症#的#急性心肌梗死#患者住院预后

JAHA：伴有原发性血小板增多症和真性红细胞增多症的急性心肌梗死患者住院预后

2022-12-16发表于上海

赛华佗 (审核中...)

前往app查看评论内容

#真性红细胞增多症#

2018 奥地利建议：真性红细胞增多症的管理

2022-05-17

赛华佗 (审核中...)

前往app查看评论内容

#真性红细胞增多症#

2018 SIE共识建议：放血疗法治疗真性红细胞增多症

2022-05-17

赛华佗 (审核中...)

前往app查看评论内容

#真性红细胞增多症#

真性红细胞增多症诊断与治疗中国专家共识（2016年版）

2022-05-17

赛华佗 (审核中...)

前往app查看评论内容

#真性红细胞增多症#

2018 BSH指南：真性红细胞增多症的诊断和管理

2022-05-17

赛华佗 (审核中...)

前往app查看评论内容

#真性红细胞增多症#

2021 ELN建议：合理应用细胞减少药物治疗真性红细胞增多症

2022-05-17

科室
- - 订阅+
  - 更多科室
工具
服务